Assertio Holdings is back in focus after its fair value estimate was reset from US$37.44 to US$21.33, a cut of roughly 43% that reflects a more cautious stance on the stock. Analysts are weighing this ...

While the proven Zacks Rank places an emphasis on earnings estimates and estimate revisions to find strong stocks, we also know that investors tend to develop their own individual strategies. With ...

In the latest trading session, Assertio (ASRT) closed at $1.14, marking a -1.72% move from the previous day. This move lagged the S&P 500's daily gain of 0.19%. At the same time, the Dow added 0.31%, ...

Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Assertio (ASRT) is a stock that can certainly grab the attention of many investors, ...

Assertio Holdings (ASRT) is scheduled to report earnings on March 10, 2025. The last reported earnings were for reported on November 11, 2024 for Q3.

Detailed price information for Assertio Therapeutics Inc (ASRT-Q) from The Globe and Mail including charting and trades.

We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish on can be a profitable strategy for retail ...

Shares of Assertio (ASRT) have gained 16.3% over the past four weeks to close the last trading session at $14, but there could still be a solid upside left in the stock if short-term price targets of ...

Assertio Holdings ASRT will report second-quarter 2022 results on Aug 8, before market open. In the second-quarter 2022 results, we expect investors to focus on the sales performance of Assertio’s ...